Sharyn D. Baker

Sharyn D. Baker's work focuses on how drugs used to treat cancer, especially pediatric leukemia and brain tumors, are absorbed, processed, and cleared by the body (pharmacokinetics), and how this relates to drug effectiveness and side effects (pharmacodynamics). Much of the research combines clinical drug trials with genomic analysis of pediatric acute myeloid leukemia to better categorize the disease and guide treatment decisions. The work is largely collaborative, involving large research consortia and shared datasets from clinical trials.

Publication output was relatively steady and modest from 2017-2022, then spiked dramatically in 2023 (largely due to multiple linked data/supplementary records from a few studies) before settling to a higher but more moderate level in 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026